About Dementias Platform
Dementias Platform is a company based in Oxford (United Kingdom) founded in 2014 by Feyi Raimi-Abraham. It operates as a B2B and Non-Profit Collaboration. Dementias Platform offers products and services including Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator. Dementias Platform operates in a competitive market with competitors including Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
- Headquarter Oxford, United Kingdom
- Founders Feyi Raimi-Abraham
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Dementias Platform
Dementias Platform offers a comprehensive portfolio of products and services, including Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator.
Secure platform for accessing health research records and datasets
System to match volunteers to dementia studies across the UK
Accelerates development of new dementia treatments and therapies
Funding Insights of Dementias Platform
Detailed funding history for Dementias Platform
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Dementias Platform
Investment portfolio details for Dementias Platform
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Dementias Platform
Detailed financials for Dementias Platform
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Dementias Platform Comparisons
Peer comparison for Dementias Platform
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Dementias Platform
Dementias Platform operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based patient recruitment platform
|
|
| Locked | Locked | Locked |
Cloud-based SaaS solutions for clinical trial startup are offered.
|
|
| Locked | Locked | Locked |
Provider of an online scientific sourcing tool for researchers and professionals
|
|
| Locked | Locked | Locked |
Provides an online database of clinical trial studies for researchers.
|
|
| Locked | Locked | Locked |
Online Clinical Research Marketplace
|
Detailed competitors of Dementias Platform
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Dementias Platform
Complete news archive for Dementias Platform
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dementias Platform
Dementias Platform was founded in 2014.
Dementias Platform is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Feyi Raimi-Abraham is the current CEO of Dementias Platform. They have also founded this company.
Dementias Platform UK (DPUK) is a collaborative initiative in the UK that unites scientists and pharmaceutical leaders to advance dementia detection, treatment, and prevention. It provides a secure data portal for accessing health records, a framework for matching volunteers to clinical trials, and an incubator for developing new therapies. Through partnerships with universities and organizations, DPUK conducts research studies and offers training, aiming to improve early diagnosis and support global collaborations.
Dementias Platform offers Data Portal, Trials Delivery Framework, and Experimental Medicine Incubator.